White Matter Lesion Penumbra Shows Abnormalities on Structural and Physiologic MRIs in the Coronary Artery Risk Development in Young Adults Cohort

REFERENCES

1. 1.↵
   2. Launer LJ,
   3. Lewis CE,
   4. Schreiner PJ, et al

   . Vascular factors and multiple measures of early brain health: CARDIA Brain MRI Study. PLoS One 2015;10:e0122138 doi:10.1371/journal.pone.0122138 pmid:25812012

   CrossRefPubMed
2. 2.↵
   2. Jokinen H,
   3. Kalska H,
   4. Ylikoski R, et al

   ; LADIS group. Longitudinal cognitive decline in subcortical ischemic vascular disease: the LADIS study. Cerebrovasc Dis 2009;27:384–91 doi:10.1159/000207442 pmid:19276621

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Verdelho A,
   3. Madureira S,
   4. Moleiro C, et al

   ; LADIS Study. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010;75:160–67 doi:10.1212/WNL.0b013e3181e7ca05 pmid:20625169

   Abstract/FREE Full Text
4. 4.↵
   2. Debette S,
   3. Markus HS

   . The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666 doi:10.1136/bmj.c3666 pmid:20660506

   Abstract/FREE Full Text
5. 5.↵
   2. Teodorczuk A,
   3. Firbank MJ,
   4. Pantoni L, et al

   ; LADIS Group. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study. Psychol Med 2010;40:603–10 doi:10.1017/S0033291709990857 pmid:19671212

   CrossRefPubMed
6. 6.↵
   2. Inzitari D,
   3. Pracucci G,
   4. Poggesi A, et al

   ; LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three-year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009;339:b2477 doi:10.1136/bmj.b2477 pmid:19581317

   Abstract/FREE Full Text
7. 7.↵
   2. de Groot M,
   3. Verhaaren BF,
   4. de Boer R, et al

   . Changes in normal-appearing white matter precede development of white matter lesions. Stroke 2013;44:1037–42 doi:10.1161/STROKEAHA.112.680223 pmid:23429507

   Abstract/FREE Full Text
8. 8.↵
   2. Brown WR,
   3. Thore CR

   . Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011;37:56–74 doi:10.1111/j.1365-2990.2010.01139.x pmid:20946471

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Fazekas F,
   3. Kleinert R,
   4. Offenbacher H, et al

   . Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683–89 doi:10.1212/WNL.43.9.1683 pmid:8414012

   Abstract/FREE Full Text
10. 10.↵
    2. O'Sullivan M,
    3. Lythgoe DJ,
    4. Pereira AC, et al

    . Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology 2002;59:321–26 doi:10.1212/WNL.59.3.321 pmid:12177363

    Abstract/FREE Full Text
11. 11.↵
    2. Brickman AM,
    3. Zahra A,
    4. Muraskin J, et al

    . Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging. Psychiatry Res 2009;172:117–20 doi:10.1016/j.pscychresns.2008.11.006 pmid:19324534

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Sam K,
    3. Crawley AP,
    4. Poublanc J, et al

    . Vascular dysfunction in leukoaraiosis. AJNR Am J Neuroradiol 2016;37:2258–64 doi:10.3174/ajnr.A4888 pmid:27492072

    Abstract/FREE Full Text
13. 13.↵
    2. Topakian R,
    3. Barrick TR,
    4. Howe FA, et al

    . Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry 2010;81:192–97 doi:10.1136/jnnp.2009.172072 pmid:19710048

    Abstract/FREE Full Text
14. 14.↵
    2. Grueter BE,
    3. Schulz UG

    . Age-related cerebral white matter disease (leukoaraiosis): a review. Postgrad Med J 2012;88:79–87 doi:10.1136/postgradmedj-2011-130307 pmid:22184252

    Abstract/FREE Full Text
15. 15.↵
    2. Conklin J,
    3. Silver FL,
    4. Mikulis DJ, et al

    . Are acute infarcts the cause of leukoaraiosis? Brain mapping for 16 consecutive weeks. Ann Neurol 2014;76:899–904 doi:10.1002/ana.24285 pmid:25283088

    CrossRefPubMed
16. 16.↵
    2. Promjunyakul N,
    3. Lahna D,
    4. Kaye JA, et al

    . Characterizing the white matter hyperintensity penumbra with cerebral blood flow measures. Neuroimage Clin 2015;8:224–29 doi:10.1016/j.nicl.2015.04.012 pmid:26106546

    CrossRefPubMed
17. 17.↵
    2. Maniega SM,
    3. Valdés Hernandez MC,
    4. Clayden JD, et al

    . White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiol Aging 2015;36:909–18 doi:10.1016/j.neurobiolaging.2014.07.048 pmid:25457555

    CrossRefPubMed
18. 18.↵
    2. Bernbaum M,
    3. Menon BK,
    4. Fick G, et al

    . Reduced blood flow in normal white matter predicts development of leukoaraiosis. J Cereb Blood Flow Metab 2015;35:1610–15 doi:10.1038/jcbfm.2015.92 pmid:25966951

    CrossRefPubMed
19. 19.↵
    2. Schmidt R,
    3. Ropele S,
    4. Ferro J, et al

    ; LADIS study group. Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study. Stroke 2010;41:e402–08 doi:10.1161/STROKEAHA.109.576629 pmid:20203319

    Abstract/FREE Full Text
20. 20.↵
    2. Pelletier A,
    3. Periot O,
    4. Dilharreguy B, et al

    . Age-related modifications of diffusion tensor imaging parameters and white matter hyperintensities as inter-dependent processes. Front Aging Neurosci 2016;7:255 doi:10.3389/fnagi.2015.00255 pmid:26834625

    CrossRefPubMed
21. 21.↵
    2. Maillard P,
    3. Carmichael O,
    4. Harvey D, et al

    . FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am J Neuroradiol 2013;34:54–61 doi:10.3174/ajnr.A3146 pmid:22700749

    Abstract/FREE Full Text
22. 22.↵
    2. Friedman GD,
    3. Cutter GR,
    4. Donahue RP, et al

    . CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105–16 doi:10.1016/0895-4356(88)90080-7 pmid:3204420

    CrossRefPubMedWeb of Science
23. 23.↵
    2. Shen D,
    3. Davatzikos C

    . HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging 2002;21:1421–39 doi:10.1109/TMI.2002.803111 pmid:12575879

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Zacharaki EI,
    3. Kanterakis S,
    4. Bryan RN, et al

    . Measuring brain lesion progression with a supervised tissue classification system. Med Image Comput Comput Assist Interv 2008;11:620–27 pmid:18979798

    PubMed
25. 25.↵
    2. Lao Z,
    3. Shen D,
    4. Liu D, et al

    . Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol 2008;15:300–13 doi:10.1016/j.acra.2007.10.012 pmid:18280928

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Wang Z,
    3. Aguirre GK,
    4. Rao H, et al

    . Empirical optimization of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magn Reson Imaging 2008;26:261–69 doi:10.1016/j.mri.2007.07.003 pmid:17826940

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Murphy K,
    3. Harris AD,
    4. Wise RG

    . Robustly measuring vascular reactivity differences with breath-hold: normalising stimulus-evoked and resting state BOLD fMRI data. Neuroimage 2011;54:369–79 doi:10.1016/j.neuroimage.2010.07.059 pmid:20682354

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Uh J,
    3. Yezhuvath U,
    4. Cheng Y, et al

    . In vivo vascular hallmarks of diffuse leukoaraiosis. J Magn Reson Imaging 2010;32:184–90 doi:10.1002/jmri.22209 pmid:20578025

    CrossRefPubMed
29. 29.↵
    2. Reich T,
    3. Rusinek H

    . Cerebral cortical and white matter reactivity to carbon dioxide. Stroke 1989;20:453–57 doi:10.1161/01.STR.20.4.453 pmid:2494780

    Abstract/FREE Full Text
30. 30.↵
    2. Guyon I,
    3. Weston J,
    4. Barnhill S, et al

    . Gene selection for cancer classification using support vector machines. Machine Learning 2002;46:389–422 doi:10.1023/A:1012487302797

    CrossRef
31. 31.↵
    2. Kuller LH,
    3. Margolis KL,
    4. Gaussoin SA, et al

    ; Women's Health Initiative Memory Study Research Group. Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) 2010;12:203–12 doi:10.1111/j.1751-7176.2009.00234.x pmid:20433539

    CrossRefPubMed
32. 32.↵
    2. Nasrallah IM

    ; Alzheimer's Association International Conference. A Randomized Trial of Intensive Versus Standard Systolic Blood Pressure Control and Brain Structure: SPRINT MIND MRI. Chicago, IL; July 25, 2018
33. 33.↵
    2. Matsushita K,
    3. Kuriyama Y,
    4. Nagatsuka K, et al

    . Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients. Hypertension 1994;23:565–68 doi:10.1161/01.HYP.23.5.565 pmid:8175162

    CrossRefPubMed
34. 34.↵
    2. Bakker SL,
    3. de Leeuw FE,
    4. de Groot JC, et al

    . Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 1999;52:578–83 doi:10.1212/WNL.52.3.578 pmid:10025791

    Abstract/FREE Full Text
35. 35.↵
    2. Birns J,
    3. Jarosz J,
    4. Markus HS, et al

    . Cerebrovascular reactivity and dynamic autoregulation in ischaemic subcortical white matter disease. J Neurol Neurosurg Psychiatry 2009;80:1093–98 doi:10.1136/jnnp.2009.174607 pmid:19535355

    Abstract/FREE Full Text